Investors including SOSV, Cultivate(MD), Wavemaker360 Health, Blu Venture Investors and Broad Street Angels are backing Strados Labs LLC with $4.5 million. The pre-series A funding will be used to accelerate development of the company’s smart sensor platform Resp. The funding comes after Strados received FDA clearance for the product in December 2021 and brings its total raised to $7 million.
Be careful who you’re doing business with. That’s the warning the U.S. Court of Appeals for the District of Columbia Circuit sent this week to multinational drug and device companies doing business in terrorist hot spots around the world. Reversing a lower court, the D.C. Circuit cleared the way Jan. 4 for 21 drug and device companies to potentially be held accountable for doing business with Jaysh al-Mahdi terrorists, operating through the Iraqi Ministry of Health, who injured or killed hundreds of U.S. troops and civilians in Iraq.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Endotronix, Nuvasive.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adagio, Akoya, Applied Medical Solutions, Bio-Techne, Bosch, Cardx, Diacarta, Highmark Health, Laborie Medical, Metavention, Nanovibronix, Neovasc, Nuvo, Thermo Fisher Scientific, The Transplant Pharmacy.
New hires and promotions in the med-tech industry, including: Avellino Labs, Bluejay Diagnostics, Gattaco, Miromatrix Medical, Myriad Genetics, Summit Biolabs.
Over the course of the past two years, two presidential administrations and the U.S. Congress have set considerable sums of money aside for testing for the COVID-19 pandemic, but reports of shortages of tests have prompted a response from Capitol Hill.
FDA recalls are fairly commonplace events and infrequently require any field corrections of inventory on the market, but Puritan-Bennett Corp. has asked customers to quarantine 135 of the company’s 980 series ventilators due to assembly problems that could cause the devices to cease operating.
Synchron Inc. closed out 2021 by providing an opening for a patient with amyotrophic lateral sclerosis (ALS) to send the first thought transferred to a tweet via an implantable brain computer interface. Philip O’Keefe, who received one of the company’s Stentrode implants in April 2020, took over the Twitter account of Sychron CEO Thomas Oxley to say, “Hello, World. Short tweet. Monumental progress.”
Researchers at the University of Pennsylvania’s Perelman School of Medicine have shown how nanoparticles could be used to reduce neutrophil clumping in inflamed lungs – making them a pathway for diagnosis and treatment of acute lung inflammation (ALI) and acute respiratory distress syndrome (ARDS).
RSS
